229 Users Online
Cosmetic CDMO Market Segmented by Contract Development (Formulation Development, Pilot Studies), Contract Manufacturing (Bulk Preparation & Scale Up, Safety Testing, Filling & Packaging)
Worldwide revenue from the cosmetic CDMO market is estimated at US$ 21.2 Bn in 2022, with the global market predicted to surge ahead at a CAGR of 6% to reach a valuation of US$ 37.9 Bn by the end of 2032.
As assessed by Persistence Market Research, contract manufacturing is expected to hold a market value of around US$ 25.8 Bn by the end of 2032. Overall, cosmetic CDMO sales account for approximately 11.7% revenue share of the global contract development and manufacturing organization (CDMO) market, which was valued at US$ 171.1 Bn in 2021.
The global market for cosmetic CDMOs recorded a historic CAGR of 4.9% in the last 5 years from 2016 to 2021. The purchasing preferences of consumers nowadays have significantly changed. Mass-produced personal care and beauty products are less popular; instead, people are more inclined to choose specialized products and distinctive brands that complement their lifestyles. Customers also have serious reservations regarding the products' components, manufacturing process, and packaging.
Because they can heighten production costs, developing products using these kinds of values and components may be difficult for an in-house production team. To satisfy consumer demand and manage costs, outsourcing to a cosmetic contract manufacturer is becoming increasingly popular.
The COVID-19 pandemic increased public awareness about the need to exercise strict health precautions and use safe, hygienic products. Since the personal care and beauty sectors are not exempt from this problem, producers are being encouraged to focus more on healthy products.
Furthermore, the relevance of makeup and fragrance has declined as a result of working from home, physical & social distance, and the use of masks. However, sanitizers, skincare, hair care, and bath and body products appear to be the most popular at present.
Contract manufacturing allows enterprises to efficiently produce and sell their products in areas with strict regulatory laws and import restrictions. As a result, working with CMOs and CDMOs has gained a lot of popularity as an approach to improve distribution and growth.
Cosmetic CDMO Market Size (2022)
US$ 21.2 Bn
Projected Market Value (2032)
US$ 37.9 Bn
Global Market Growth Rate (2022-2032)
Market Share of Top 5 Countries
“Importance of Lowering Production Costs”
In recent years, there has been a noticeable rise in consumer demand for natural/herbal beauty products, which has expanded the use of herbal ingredients in a wider range of cosmetic and personal care products.
Businesses are also working harder to transition away from synthetic chemicals and toward natural ingredients, largely in response to rising customer demand and in an effort to locate a sustainable raw material source. Manufacturers are under intense pressure to focus on mass-producing herbal cosmetics to keep up with consumer demand. Businesses are outsourcing their manufacturing processes to third-party CMOs to fulfil this ongoing demand, which also contributes to the industry's rapid CMO expansion in the cosmetics and personal care market.
CMOs also give businesses the ability to focus on their core strengths and increase production throughput while lowering production costs. These organizations have well-known vendor lists, storage lists, large manufacturing facilities, and distribution networks. Due to these benefits, there is an increasing demand for third-party production, particularly of herbal cosmetics, thus providing vast opportunities for growth in the market.
Demand for private label brands has increased due to changes in consumer preferences in the marketplace, which are also expected to provide CMOs with opportunities in the near future. The key reasons for the change are price, accessibility, selection, and reviews & ratings. Major drivers for the increase in demand for private-label brands are e-Commerce and social medicine.
“Threat of Intellectual Property Theft”
One key downside of contract manufacturing is the danger of intellectual property theft. The process entails transferring the patented designs of items to the CMO, which provides the manufacturer and other workers access to patented information. Since the manufacturer might utilize that information without a license, there is some risk involved. Additionally, this might result in the theft or leaking of intellectual property. Suppliers might exploit it to their advantage and potentially become competitors.
Additionally, when a service is outsourced, the company loses control of the process. There is a chance of losing vital production-related knowledge and skills when this control is turned over. This may put the product's quality and other crucial components of production at risk.
Also, a lack of effective communication is another reason why businesses hesitate to outsource their needs. During the production process, this could lead to several issues, including those with schedules, transition plans, internal communications, and capacity qualification, among others.
These variables may restrict the expansion of contract manufacturers on a global scale.
Why is the U.S. Cosmetic CDMO Industry Booming?
“Collaboration among Companies and Established CDMOs”
The U.S. accounted for 80.6% market share of the North American market in 2021, growing at a CAGR of close to 6.0%, and a similar trend is expected over the expanding period. There is the presence of a large number of established CDMOs in the country. Moreover, growing collaborations between pharmaceutical and biopharmaceutical companies with contract manufacturing organizations are further accelerating the growth of the market in the country. Rising disposable income is another factor that is driving market growth in the U.S.
Will Italy Be a Lucrative Market for Cosmetic CDMO Service Providers?
“Italy - Hub for Contract Development & Manufacturing Organizations”
Italy held 21.4% share of the Europe cosmetic CDMO market in 2021. The largest manufacturer of CDMOs in Europe is Italy.
How is China Emerging as a Prominent Market for Cosmetic CDMO Services?
“Tapping Global Markets and Enhancing Healthcare Sector”
China held the largest market share of 52.5% of the East Asia cosmetic CDMO market in 2021.
Primary factors driving the growth of the Chinese market include the country's recent rapid transformation of its healthcare sector, recent amendments to its Drug Administration Law, and Chinese pharmaceutical businesses' ambition to access global markets.
Which Service is Driving Market Growth of Cosmetic CDMOs?
“High Demand for Development & Manufacturing of Products across Regions”
Contract manufacturing held 69.3% share of the total market in 2021. The fact that contract manufacturing boosts a producer's earnings is its biggest benefit. A business can focus on a specific set of responsibilities and discover how to optimize each one by outsourcing manufacturing to a contract manufacturer.
Additionally, by lowering demand uncertainty and enabling general manufacturers to concentrate on what they do best without having to worry about acquiring resources and components, contract manufacturing enables specialization and innovation.
Which Product Drives Most Revenue for Market Players?
“GMP-Compliant Production of Products Catering to Mass Demand”
Skin products held the largest market share of 39.9% in 2021.
Cosmetic CDMO facilities are an excellent option to mass-produce huge quantities of products in a safe and controlled environment. To achieve the best results, quality control and safety measures are strictly followed. This market is driven by the high demand for skin moisturizing and sanitizing products, which is in turn driven by the rising global awareness of skincare and aesthetics.
To foster the innovative outcomes and development frameworks required for future success, key players concentrate on entering strategic agreements and becoming innovation partners to high-growth businesses. Market players are staying up to date with trends and are continuously searching for new and innovative active ingredients or product formulations.
Historical Data Available for
USD Million for Value
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Customization & Pricing
Available upon Request
The global cosmetic CDMO market stands at around US$ 21.1 Bn in 2022.
Revenue of cosmetic CDMOs is set to witness a high growth rate of 6% and be valued at US$ 37.9 Bn by 2032.
Demand for cosmetic CDMOs increased at 4.9% CAGR from 2016 to 2021.
The U.S., India, China, Australia, and Japan account for the most demand for cosmetic CDMO services, currently holding 55% market share.
The U.S. accounts for 80.6% share of the North American market.
Swiss American CDMO, Pierre Fabre Group, and Zymo Cosmetics are the top three companies in this market.
China held a share of 52.5% of the East Asia cosmetic CDMO market in 2021, while Japan held a share of 34.7%.
The market in India is set to expand at a CAGR of 5% through 2032.
The market in Italy is set to expand at a CAGR of 4.8% during the forecasted years.